Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-14 4:18 pm Sale | 13G | Palantir Technologies Inc. PLTR | THIEL PETER | 148,925,737 7.100% | -14,539,442 (-8.89%) | View |
2023-04-24 4:53 pm Unchanged | 13D | ABCELLERA BIOLOGICS INC. ABCL | THIEL PETER | 14,360,427 4.990% | 0 (Unchanged) | View |
2023-02-14 4:06 pm Unchanged | 13G | Palantir Technologies Inc. PLTR | THIEL PETER | 163,465,179 8.100% | 0 (Unchanged) | View |
2022-09-09 4:15 pm Purchase | 13G | PROPERTYGURU GROUP LTD PGRU | THIEL PETER | 10,195,197 6.100% | 10,195,197 (New Position) | View |
2022-02-14 4:20 pm Sale | 13G | Palantir Technologies Inc. PLTR | THIEL PETER | 163,465,179 8.400% | -104,980,465 (-39.11%) | View |
2022-02-14 4:17 pm Sale | 13G | COMPASS Pathways plc CMPS | THIEL PETER | 1,305,788 3.100% | -1,046,728 (-44.49%) | View |
2021-03-26 08:10 am Purchase | 13G | CHEMOMAB THERAPEUTICS LTD CMMB | THIEL PETER | 22,631,260 10.600% | 22,631,260 (New Position) | View |
2021-02-16 4:46 pm Purchase | 13G | Palantir Technologies Inc. PLTR | THIEL PETER | 268,445,644 16.600% | 268,445,644 (New Position) | View |
2021-02-16 4:01 pm Purchase | 13G | COMPASS Pathways plc CMPS | THIEL PETER | 2,352,516 6.500% | 2,352,516 (New Position) | View |
2020-12-28 4:48 pm Purchase | 13D | ABCELLERA BIOLOGICS INC. ABCL | THIEL PETER | 14,360,427 5.300% | 14,360,427 (New Position) | View |